BCR and chronic myelogenous leukemia, BCR-ABL1 positive: For example, in chronic myelogenous leukemia, the high tyrosine kinase activity of the chimeric BCR-ABL protein is derived from the fusion of the phosphorylation domain encoded by the BCR gene with the non-receptor tyrosine kinase domain encoded from the ABL proto-oncogene [4].